Arbutus Biopharm

ABUS NASDAQ
1.480
+0.020
+1.37%
已收盘, 16:00 08/21 EDT
开盘
1.470
昨收
1.460
最高
1.510
最低
1.430
成交量
10.05万
成交均量(3M)
46.11万
52周最高
11.25
52周最低
1.380
换手率
0.18%
市值
8,413.83万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Arbutus Biopharm ABUS股票价格,Arbutus Biopharm股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple mechanisms of action that results in a combination therapy to cure HBV. In addition to its HBV pipeline, the Company actively licenses its Lipid Nanoparticle (LNP) technology to its industry partners. This technology represents a delivery technology in RNA interference (RNAi) therapeutic development, which has enabled several clinical trials and has been administered to hundreds of human subjects.
展开 >

最近浏览

名称
价格
涨跌幅